Request for Information (RFI): Potential of Wearable Devices in Cancer Research and Care

Funding Agency:
National Institutes of Health

This Request for Information (RFI) is to solicit inputs on the use and development of wearable technologies for cancer diagnosis, treatment, and treatment follow-up.

Wearable devices are becoming ubiquitous in society and can potentially improve cancer research and care and mitigate the financial burden of cancer. Wearable devices offer immediate medical benefits, including improved adherence to medical treatments and the accuracy of symptom tracking over self-reported data.

Most existing wearable devices track physical activity (e.g., steps and heart rate) and exercise regimes in-real time. These features are highly valuable for monitoring of well-being and physical activity of the patient under treatment. It is also feasible that next-generation wearable devices will be capable of monitoring physiological biomarkers (from sweat and epidermis, for example) and thus will allow for improved cancer diagnosis, treatment, and treatment follow-up.

The fast development of information technologies such as artificial intelligence and data analytics, paired with smart devices will influence the design of wearable devices and analysis of data collected by them and can result in the development of miniature devices with increased number of functions.

Through this Request for Information (RFI), the National Cancer Institute (NCI) seeks stakeholders’ inputs and comments on the value of wearable technologies to cancer diagnosis, treatment, and treatment follow-up.

Responses to this RFI must be submitted electronically to NCIWearablesRFI@mail.nih.govResponses must be received by 11:59 p.m. on May 2, 2022.




Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 2, 2022